Anticholinergic medications in patients admitted with cognitive impairment or falls (AMiCI). The impact of hospital admission on anticholinergic cognitive medication burden. Results of a multicentre observational study.
I Weichert,
R Romero-Ortuno,
J Tolonen,
T Soe,
C Lebus,
S Choudhury,
CV Nadarajah,
P Nanayakkara,
M Orrù,
S Di Somma,
Global Research on Acute Conditions Team (GREAT)
May 11, 2018
WHAT IS KNOWN AND OBJECTIVE: Drugs with anticholinergic properties increase the risk of falls, delirium, chronic cognitive impairment, and mortality and counteract procholinergic medications used in the treatment of dementia....